Quest Investment Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$640K Sell
14,988
-51,466
-77% -$2.79M 0.07% 88
2026
Q1
$4.17M Sell
66,454
-20,880
-24% -$1.67M 0.49% 54
2025
Q4
$8.33M Buy
87,334
+1,149
+1% +$113K 0.9% 31
2025
Q3
$8.41M Sell
86,185
-35,363
-29% -$3.66M 0.88% 40
2025
Q2
$13.1M Sell
121,548
-6,812
-5% -$689K 1.43% 24
2025
Q1
$12.9M Sell
128,360
-20,528
-14% -$2.07M 1.6% 25
2024
Q4
$13.3M Buy
148,888
+134,237
+916% +$11.8M 1.54% 27
2024
Q3
$1.23M Buy
+14,651
New +$1.15M 0.14% 60

Other funds holding BSX

Quest Investment Management's BSX Position: Q2 2026 in Review

Quest Investment Management reduced its Boston Scientific (BSX) stake by 77% in Q2 2026, selling an estimated $2.79M and leaving 14,988 shares worth $640K. The position accounts for 0.07% of the portfolio, ranked #88.

Quest Investment Management first reported a position in BSX in Q3 2024 and has held it in 8 quarters since. The position peaked at $13.3M in Q4 2024. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Quest Investment Management held 14,988 shares of Boston Scientific worth $640K as of Q2 2026.
  • Quest Investment Management sold 51,466 Boston Scientific shares in Q2 2026, an estimated $2.79M.
  • Boston Scientific made up 0.07% of Quest Investment Management's portfolio in Q2 2026, its #88 holding.
  • Quest Investment Management first reported a position in Boston Scientific in Q3 2024 and has held it in 8 quarters since.
  • Quest Investment Management's Boston Scientific position peaked at $13.3M in Q4 2024.
  • 1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Quest Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.